IP Library Assignment 071351/0192
Patent Assignment
Reel/Frame 071351/0192

Change of Address

Recorded: 2025-04-16 Pages: 3
Assignor
Assignee
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
GSK MEDICINES RESEARCH CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2NY, UNITED KINGDOM
Covered Properties (22)
Novel Use
Application: 17/790,218 →
Publication: US US20240173290A1
Novel Use
Application: 17/812,299 →
Publication: US US20230220037A1
Anti-ULBP6 Antibodies
Application: 18/309,272 →
Publication: US US20230348604A1
Selective P2X3 Modulators
Application: 15/936,316 →
Benzoimidazole Compounds and Uses Thereof
Patent: 8,530,467 →
Application: 13/472,825 →
Publication: US US20120289504A1
Imidazopyridine Compounds and Uses Thereof
Patent: 9,598,409 →
Application: 14/764,404 →
Publication: US US20150361078A1
Treatment of Pruritus with P2X3 Modulators
Application: 17/283,904 →
Publication: US US20210346391A1
Crystalline Forms of a Substituted Imidazopyridine Compound and Use Thereof as P2X3 Modulator
Application: 17/292,663 →
Publication: US US20220002292A1
Treatment with P2X3 Modulators
Application: 17/461,988 →
Publication: US US20210386751A1
Preparation of a P2X3 Antagonist
Application: 17/929,027 →
Publication: US US20230101612A1
P2X3 Modulators
Application: 17/929,035 →
Publication: US US20230312557A1
Imidazopyridine Compounds and Uses Thereof
Patent: 9,814,725 →
Application: 15/423,428 →
Publication: US US20170143730A1
Imidazopyridine Compounds and Uses Thereof
Patent: 9,937,185 →
Application: 15/716,410 →
Publication: US US20180015099A1
Selective P2X3 Modulators
Application: 17/932,200 →
Publication: US US20230248736A1
Use of Oligonucleotides for Individuals with Renal Impairment
Application: 18/577,450 →
Publication: US US20240336921A1
Compositions and Methods for Treatment of Hepatitis D Virus Infection
Application: 17/304,479 →
Publication: US US20210403908A1
Rnai Agents for Hepatitis B Virus Infection
Application: 17/396,378 →
Publication: US US20210395745A1
Preparation of P2X3 Antagonist
Application: 18/683,520 →
Publication: US US20240351992A1
Treatment of Pruritus with P2X3 Modulators
Application: 18/665,688 →
Publication: US US20240299404A1
Prevention and Treatment of Headaches
Application: 18/832,579 →
Publication: US US20250154236A1
Covalent Multi-Specific Antibody
Application: 17/596,789 →
Publication: US US20230192898A1
Covalent Multi-Specific Antibody
Application: 18/668,012 →
Publication: US US20240352155A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 3, 2012
From: CANTIN, LOUIS-DAVID; LUO, XUEHONG; TOMASZEWSKI, MIROSLAW JERZY
To: ASTRAZENECA CANADA INC.
Reel/Frame 029069/0496 →
Assignment of Assignor's Interest Oct 3, 2012
From: ASTRAZENECA CANADA INC.
To: ASTRAZENECA AB
Reel/Frame 029069/0524 →
Assignment of Assignor's Interest Dec 21, 2012
From: ASTRAZENECA AB
To: NEOMED INSTITUTE
Reel/Frame 029518/0326 →
Assignment of Assignor's Interest Aug 30, 2017
From: BUON, CHRISTOPHE; CANTIN, LOUIS-DAVID; HU, YUN-JIN; LUO, XUEHONG
To: ASTRAZENECA CANADA INC.
Reel/Frame 043452/0396 →
Assignment of Assignor's Interest Aug 30, 2017
From: ASTRAZENECA AB
To: NEOMED INSTITUTE
Reel/Frame 043452/0586 →
Assignment of Assignor's Interest Aug 30, 2017
From: ASTRAZENECA CANADA INC.
To: ASTRAZENECA AB
Reel/Frame 043452/0480 →
Corrective Assignment to Correct the Effective and Execution Date Previously Recorded at Reel: 043452 Frame: 0480. Assignor(S) Hereby Confirms the Assignment. Sep 27, 2017
From: ASTRAZENECA CANADA INC.
To: ASTRAZENECA AB
Reel/Frame 044040/0218 →
Assignment of Assignor's Interest Feb 26, 2018
From: BUON, CHRISTOPHE; CANTIN, LOUIS-DAVID; HU, YUN-JIN; LUO, XUEHONG
To: ASTRAZENECA CANADA INC.
Reel/Frame 045034/0906 →
Assignment of Assignor's Interest Feb 26, 2018
From: ASTRAZENECA AB
To: NEOMED INSTITUTE
Reel/Frame 045035/0418 →
Assignment of Assignor's Interest Feb 26, 2018
From: ASTRAZENECA CANADA INC.
To: ASTRAZENECA CANADA AB
Reel/Frame 045035/0356 →
Assignment of Assignor's Interest Jul 12, 2018
From: PAYZA, KEMAL
To: NEOMED INSTITUTE
Reel/Frame 046336/0436 →
Assignment of Assignor's Interest Jul 12, 2018
From: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
To: NEOMED INSTITUTE
Reel/Frame 046336/0526 →
Assignment of Assignor's Interest Jul 12, 2018
From: GARCEAU, DENIS; MATZOURANIS, ANTONIOS; BELLINI, ROBERTO; CHAURET, NATHALIE
To: BELLUS HEALTH COUGH INC.
Reel/Frame 046336/0154 →
Assignment of Assignor's Interest Jul 12, 2018
From: BROWNE, SUSAN E.
To: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Reel/Frame 046336/0236 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 045035 Frame: 0356. Assignor(S) Hereby Confirms the Assignment. Dec 18, 2018
From: ASTRAZENECA CANADA INC.
To: ASTRAZENECA AB
Reel/Frame 047949/0780 →
Assignment of Assignor's Interest Oct 15, 2020
From: BUON, CHRISTOPHE; CANTIN, LOUIS-DAVID; HU, YUN-JIN; LUO, XUEHONG
To: ASTRAZENECA CANADA INC.
Reel/Frame 054065/0193 →
Assignment of Assignor's Interest Oct 15, 2020
From: ASTRAZENECA AB
To: NEOMED INSTITUTE
Reel/Frame 054065/0668 →
Assignment of Assignor's Interest Oct 15, 2020
From: ASTRAZENECA CANADA INC.
To: ASTRAZENECA AB
Reel/Frame 054065/0533 →
Assignment of Assignor's Interest Apr 20, 2021
From: MATZOURANIS, ANTONIOS; CHAURET, NATHALIE; GARCEAU, DENIS
To: BELLUS HEALTH COUGH INC.
Reel/Frame 055978/0986 →
Assignment of Assignor's Interest Jun 22, 2021
From: JANSSEN-CILAG GMBH
To: JANSSEN PHARMACEUTICALS, INC.
Reel/Frame 056617/0529 →
Assignment of Assignor's Interest Jun 22, 2021
From: JANSSEN BIOPHARMA, INC.
To: JANSSEN PHARMACEUTICALS, INC.
Reel/Frame 056617/0563 →
Assignment of Assignor's Interest Jun 22, 2021
From: KAKUDA, THOMAS NAOKI
To: JANSSEN BIOPHARMA, INC.
Reel/Frame 056617/0471 →
Assignment of Assignor's Interest Jun 22, 2021
From: BIERMER, MICHAEL
To: JANSSEN-CILAG GMBH
Reel/Frame 056617/0339 →
Assignment of Assignor's Interest Jun 22, 2021
From: JANSSEN PHARMACEUTICA NV
To: JANSSEN PHARMACEUTICALS, INC.
Reel/Frame 056617/0623 →
Assignment of Assignor's Interest Jun 22, 2021
From: KALMEIJER, RONALD CORNELIS MARIE; BEUMONT, MARIA GLORIA
To: JANSSEN PHARMACEUTICALS, INC.
Reel/Frame 056617/0215 →